Immediate mechanical thrombectomy(iMT) using EmboTrap II Revascularization Device for Cerebral Ischemia
Phase-Based Progress Estimates
Effectiveness
Safety
Cerebral IschemiaImmediate mechanical thrombectomy(iMT) using EmboTrap II Revascularization Device - Device
Study Summary
This trial will test whether patients with a certain type of stroke do better with a medical procedure than with initial medical management.
Eligible Conditions
- Cerebral Ischemia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 11 Secondary · Reporting Duration: 96 hours
24 hours post randomization
Infarct volume
Number of patients with early Neurologic Deterioration (END) comparing the two treatment arms
36 hours
Symptomatic intracranial hemorrhage (sICH) within 36 hours comparing the two treatment arms
90-day
90-day Global Disability Assessed Via the Blinded Evaluation of Modified Rankin Score (Ordinal Shift Analysis).
Health-related quality of life EQ-5D score comparing the two treatment arms
Instrumental Activities of Daily Living (IADL)
Mortality rate within 90 days comparing the two treatment arms
Number of patients with excellent outcome comparing the two treatment arms arms
Number of patients with good outcome comparing the two treatment arms
Number of patients with intracranial hemorrhages using the Heidelberg Bleeding definition comparing the two treatment arms
Self-reported PROMIS Fatigue score
Self-reported mental and physical health PROMIS Global-10 score
Shift in distribution of the 90-day mRS with levels 5-6 combined (0;1;2;3;4;5-6) comparing the two treatment arms
96 hours
Therapeutic procedure
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Trial Design
2 Treatment Groups
Initial medical management (iMM)
1 of 2
Immediate mechanical thrombectomy(iMT)
1 of 2
Active Control
Experimental Treatment
200 Total Participants · 2 Treatment Groups
Primary Treatment: Immediate mechanical thrombectomy(iMT) using EmboTrap II Revascularization Device · No Placebo Group · Phase 2 & 3
Immediate mechanical thrombectomy(iMT)Experimental Group · 2 Interventions: Immediate mechanical thrombectomy(iMT) using EmboTrap II Revascularization Device, Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device · Intervention Types: Device, Device
Initial medical management (iMM)
CombinationProduct
ActiveComparator Group · 1 Intervention: Initial medical management (iMM) · Intervention Types: CombinationProductTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 96 hours
Who is running the clinical trial?
University of CalgaryOTHER
706 Previous Clinical Trials
493,521 Total Patients Enrolled
Emory UniversityLead Sponsor
1,509 Previous Clinical Trials
2,705,806 Total Patients Enrolled
University of CincinnatiOTHER
389 Previous Clinical Trials
635,539 Total Patients Enrolled
Heidelberg UniversityOTHER
372 Previous Clinical Trials
224,647 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiOTHER
758 Previous Clinical Trials
5,421,063 Total Patients Enrolled
Raul G Nogueira, MDPrincipal InvestigatorEmory University
15 Previous Clinical Trials
353,267 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You must be between the ages of 18 and 50 years.
On CTA: Occlusion of both branches after MCA division (both M2s occluded) or occlusion of the larger diameter M2 branch
The bulk (>2/3) of the MCA territory has evidence of delayed washout on multiphase CT or ii.
You have a stroke and you have an objective neurological deficit.
Patients eligible for intravenous rt-PA should receive this therapy as soon as possible and no later than 4.
References
- Feil, Katharina, Marius Matusevicius, Moriz Herzberg, Steffen Tiedt, Clemens Küpper, Johannes Wischmann, Sonja Schönecker, et al.. 2022. “Minor Stroke in Large Vessel Occlusion: A Matched Analysis of Patients from the German Stroke Registry–endovascular Treatment (GSR‐ET) and Patients from the Safe Implementation of Treatments in Stroke–international Stroke Thrombolysis Register (SITS‐ISTR)”. European Journal of Neurology. Wiley. doi:10.1111/ene.15272.
- Feil K, Matusevicius M, Herzberg M, Tiedt S, Kupper C, Wischmann J, Schonecker S, Mengel A, Sartor-Pfeiffer J, Berger K, Dimitriadis K, Liebig T, Dieterich M, Mazya M, Ahmed N, Kellert L. Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry-Endovascular Treatment (GSR-ET) and patients from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Eur J Neurol. 2022 Jun;29(6):1619-1629. doi: 10.1111/ene.15272. Epub 2022 Feb 19.
- Raul Gomes Nogueira 2020. "Endovascular Therapy for Low NIHSS Ischemic Strokes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04167527.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments